These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 36625858)

  • 21. Cardiometabolic Differences in People Living with HIV Receiving Integrase Strand Transfer Inhibitors Compared to Non-nucleoside Reverse Transcriptase Inhibitors: Implications for Current ART Strategies.
    Vos WAJW; Vadaq N; Matzaraki V; Otten T; Groenendijk AL; Blaauw MJT; van Eekeren LE; Brinkman K; de Mast Q; Riksen NP; Stalenhoef AFH; van Lunzen J; van der Ven AJAM; Blok WL; Stalenhoef JE
    Viruses; 2024 Apr; 16(4):. PubMed ID: 38675924
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunological and virological efficacy of different antiretroviral regimens initiated during acute/recent HIV infection.
    Ambrosioni J; Farrera J; de Lazzari E; Nicolás D; Manzardo C; Hernández-Meneses MM; Mosquera MM; Ligero C; Marcos MA; Sánchez-Palomino S; Fernández E; Plana M; Miró JM;
    AIDS; 2020 Dec; 34(15):2269-2274. PubMed ID: 32910066
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interferon lambda rs368234815 ΔG/ΔG is associated with higher CD4
    Freitas IT; Tinago W; Sawa H; McAndrews J; Doak B; Prior-Fuller C; Sheehan G; Lambert JS; Muldoon E; Cotter AG; Hall WW; Mallon PWG; Carr MJ
    AIDS Res Ther; 2020 Apr; 17(1):13. PubMed ID: 32295609
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Longitudinal analysis of immune reconstitution and metabolic changes in women living with HIV: A real-world observational study.
    Wang X; Xiao J; Zhang L; Liu Y; Chen N; Deng M; Song C; Liu T; Zhang Y; Zhao H
    Chin Med J (Engl); 2023 Sep; 136(18):2168-2177. PubMed ID: 37580056
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Altered neuropsychological performance and reduced brain volumetrics in people living with HIV on integrase strand transfer inhibitors.
    O'Halloran JA; Cooley SA; Strain JF; Boerwinkle A; Paul R; Presti RM; Ances BM
    AIDS; 2019 Jul; 33(9):1477-1483. PubMed ID: 31008801
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD4/CD8 ratio normalization rates and low ratio as prognostic marker for non-AIDS defining events among long-term virologically suppressed people living with HIV.
    Han WM; Apornpong T; Kerr SJ; Hiransuthikul A; Gatechompol S; Do T; Ruxrungtham K; Avihingsanon A
    AIDS Res Ther; 2018 Sep; 15(1):13. PubMed ID: 30261902
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Virological and immunological impact of integrase inhibitor-based regimens initiated during primary HIV-1 infection.
    Veil R; Poizot-Martin I; Reynes J; Goujard C; Seng R; Delobel P; Cotte L; Duvivier C; Rey D; Tran L; Surgers L; Allavena C; Lascoux Combe C; Cheret A; Meyer L
    AIDS; 2020 Mar; 34(4):493-500. PubMed ID: 31764069
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD4
    Vivancos-Gallego MJ; Okhai H; Perez-Elías MJ; Gomez-Ayerbe C; Moreno-Zamora A; Casado JL; Quereda C; Sanz JM; Sanchez-Conde M; Serrano-Villar S; Del Campo S; Dronda F; Galan JC; Sabin CA; Moreno S
    Antivir Ther; 2020; 25(2):91-100. PubMed ID: 32338638
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Durability of different initial regimens in HIV-infected patients starting antiretroviral therapy with CD4+ counts <200 cells/mm3 and HIV-RNA >5 log10 copies/mL.
    Gianotti N; Lorenzini P; Cozzi-Lepri A; De Luca A; Madeddu G; Sighinolfi L; Pinnetti C; Santoro C; Meraviglia P; Mussini C; Antinori A; d'Arminio Monforte A;
    J Antimicrob Chemother; 2019 Sep; 74(9):2732-2741. PubMed ID: 31173639
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduction of CD8 T Cell Functionality but Not Inhibitory Capacity by Integrase Inhibitors.
    Richter E; Bornemann L; Korencak M; Alter G; Schuster M; Esser S; Boesecke C; Rockstroh J; Gunzer M; Streeck H
    J Virol; 2022 Mar; 96(5):e0173021. PubMed ID: 35019724
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Associations between integrase strand-transfer inhibitors and cardiovascular disease in people living with HIV: a multicentre prospective study from the RESPOND cohort consortium.
    Neesgaard B; Greenberg L; Miró JM; Grabmeier-Pfistershammer K; Wandeler G; Smith C; De Wit S; Wit F; Pelchen-Matthews A; Mussini C; Castagna A; Pradier C; d'Arminio Monforte A; Vehreschild JJ; Sönnerborg A; Anne AV; Carr A; Bansi-Matharu L; Lundgren JD; Garges H; Rogatto F; Zangerle R; Günthard HF; Rasmussen LD; Necsoi C; van der Valk M; Menozzi M; Muccini C; Peters L; Mocroft A; Ryom L
    Lancet HIV; 2022 Jul; 9(7):e474-e485. PubMed ID: 35688166
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment outcomes of integrase inhibitors, boosted protease inhibitors and nonnucleoside reverse transcriptase inhibitors in antiretroviral-naïve persons starting treatment.
    Mocroft A; Neesgard B; Zangerle R; Rieger A; Castagna A; Spagnuolo V; Antinori A; Lampe FC; Youle M; Vehreschild JJ; Mussini C; Borghi V; Begovac J; Duvivier C; Gunthard HF; Rauch A; Tiraboschi J; Chkhartishvili N; Bolokadze N; Wit F; Wasmuth JC; De Wit S; Necsoi C; Pradier C; Svedhem V; Stephan C; Petoumenos K; Garges H; Rogatto F; Peters L; Ryom L;
    HIV Med; 2020 Oct; 21(9):599-606. PubMed ID: 32588958
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiretroviral Therapy Anchor-based Trends in Body Mass Index Following Treatment Initiation Among Military Personnel with HIV.
    Kline MDA; Daniels C; Xu X; Sunil T; Ganesan A; Agan BK; Colombo RE; Kronmann KC; Blaylock JM; Okulicz JF; Markelz AE
    Mil Med; 2021 Feb; 186(3-4):279-285. PubMed ID: 33128552
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Weight change with integrase strand transfer inhibitors among virally suppressed Thai people living with HIV.
    Han WM; Kerr SJ; Avihingsanon A; Boettiger DC
    J Antimicrob Chemother; 2022 Nov; 77(12):3242-3247. PubMed ID: 36101517
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute HIV Infection and CD4/CD8 Ratio Normalization After Antiretroviral Therapy Initiation.
    Davy-Mendez T; Napravnik S; Zakharova O; Kuruc J; Gay C; Hicks CB; Mcgee KS; Eron JJ
    J Acquir Immune Defic Syndr; 2018 Dec; 79(4):510-518. PubMed ID: 30142143
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Similar CD4/CD8 Ratio Recovery After Initiation of Dolutegravir Plus Lamivudine Versus Dolutegravir or Bictegravir-Based Three-Drug Regimens in Naive Adults With HIV.
    Martínez-Sanz J; Ron R; Moreno E; Sánchez-Conde M; Muriel A; López Cortés LF; Blanco JR; Pineda JA; Mena Á; Calzado Isbert S; Moreno S; Serrano-Villar S
    Front Immunol; 2022; 13():873408. PubMed ID: 35432298
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association between switching to integrase strand transfer inhibitors and incident diabetes in people with HIV.
    Hwang YJ; Lesko CR; Brown TT; Alexander GC; Zalla LC; Keruly JC; Snow LN; Pytell JD; Falade-Nwulia O; Jones JL; Moore RD; Fojo AT
    AIDS; 2024 Sep; 38(11):1696-1702. PubMed ID: 38864578
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Switch rates, time-to-switch, and switch patterns of antiretroviral therapy in people living with human immunodeficiency virus in Japan, in a hospital-claim database.
    Ruzicka DJ; Kuroishi N; Oshima N; Sakuma R; Naito T
    BMC Infect Dis; 2019 Jun; 19(1):505. PubMed ID: 31182050
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rapid Initiation of Antiretroviral Therapy Following Diagnosis of Human Immunodeficiency Virus Among Patients with Commercial Insurance Coverage.
    Benson C; Emond B; Lefebvre P; Lafeuille MH; Côté-Sergent A; Tandon N; Chow W; Dunn K
    J Manag Care Spec Pharm; 2020 Feb; 26(2):129-141. PubMed ID: 31747358
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma Human Immunodeficiency Virus 1 RNA and CD4+ T-Cell Counts Are Determinants of Virological Nonsuppression Outcomes With Initial Integrase Inhibitor-Based Regimens: A Prospective RESPOND Cohort Study.
    Álvarez H; Mocroft A; Ryom L; Neesgaard B; Edwards S; Svedhem V; Günthard HF; Zangerle R; Smith C; Castagna A; d'Arminio Monforte A; Wit F; Stecher M; Lehman C; Mussini C; Fontas E; González E; Wasmuth JC; Sönnerborg A; De Wit S; Chkhartishvili N; Stephan C; Petoumenos K; Jaschinski N; Vannappagari V; Gallant J; Young L; Volny Anne A; Greenberg L; Martín-Iguacel R; Poveda E; Llibre JM;
    Clin Infect Dis; 2023 Aug; 77(4):593-605. PubMed ID: 37052343
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.